Bluejay Diagnostics Inc (NASDAQ:BJDX) currently has a daily average trading volume of 1.65M but it saw 4165899 shares traded in last market. With a market cap of 1.24M USD, the company’s current market price of $0.20 came falling about -9.98 while comparing to the previous closing price of $0.22. In past 52 weeks, the stock remained buoying in the range of price level as high as $53.28 and as low as $0.20. In the recent trading on the day, stock has struck highest price mark of $0.191 while lowest mark touched by it was $0.235.
Taking a look at 20-day trading activity of Bluejay Diagnostics Inc (BJDX) gives us an average price of $0.3256, while its current price level is -99.63% below from 52-week high level whereas it is -1.20% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.7635 while that of 200 days or SMA-200 reads an average of $7.5879. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.20% during that period while stretching the period over a month that increases to 21.24%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 25.49 which implies that the stock is in oversold territory.
Over the week, BJDX’s stock price is moving -22.52% down while it is -61.64% when we observe its performance for the past one month. Year-to-date it is -97.98% down and over the past year, the stock is showing a downside performance of -99.61%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -19.2 beaten by the consensus estimate of -9.6 for the same. The company is expected to be releasing its next quarterly report on 2024-Mar-28, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Bluejay Diagnostics Inc’s total number of outstanding shares is 6.25M. Company’s return on investment (ROI) stands at -106.84% and return on equity (ROE) at -125.25%. Stock’s beta reads 0.75. Stock has a price to book (P/B) ratio of 0.06. Its return on asset (ROA) is -97.27% on average.
